On the other hand, it has been shown that S1PR1 signaling promotes survival, proliferation, and migration of MCL and HL cells through a PI3K-dependent pathway, and might be useful as both a pharmacological target and an marker for aggressiveness [101,102,103]. The gene discussed is S1PR1; the disease is mantle cell lymphoma.